Raul Silva

Summary

Affiliation: New York University
Country: USA

Publications

  1. ncbi request reprint Treatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom setting
    Raul Silva
    New York University Child Study Center, New York, NY, USA
    Psychopharmacol Bull 41:19-33. 2008
  2. ncbi request reprint Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting
    Raul Silva
    Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA
    J Child Adolesc Psychopharmacol 15:637-54. 2005
  3. ncbi request reprint A rating scale for disruptive behavior disorders, based on the DSM-IV item pool
    Raul R Silva
    Division of Child and Adolescent Psychiatry, NYU School of Medicine, New York 10016, USA
    Psychiatr Q 76:327-39. 2005
  4. ncbi request reprint Administrative issues in child psychiatry
    Raul R Silva
    Department of Child and Adolescent Psychiatry, New York University School of Medicine, 550 First Avenue, New York, NY 10016 9196, USA
    Psychiatr Q 78:199-210. 2007
  5. ncbi request reprint Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder
    Raul R Silva
    New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Child Adolesc Psychopharmacol 16:239-51. 2006
  6. ncbi request reprint Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder
    Raul Silva
    New York University School of Medicine, New York, New York 10016, USA
    J Child Adolesc Psychopharmacol 14:555-63. 2004
  7. doi request reprint Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder
    Raul R Silva
    New York University Child Study Center, NYU School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Am Acad Child Adolesc Psychiatry 47:199-208. 2008
  8. ncbi request reprint Early intervention with traumatized children
    Raul R Silva
    Child Study Center, Division of Child and Adolescent Psychiatry, Department of Psychiatry, New York University School of Medicine, New 550 First Avenue NB21S6, New York, NY 10016, USA
    Psychiatr Q 74:333-47. 2003
  9. ncbi request reprint Dexmethylphenidate extended-release capsules for the treatment of attention deficit hyperactivity disorder
    Sharon Kowalik
    New York University School of Medicine, New York, USA
    Expert Opin Pharmacother 7:2547-57. 2006
  10. pmc Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review
    Rachel Neuhut
    Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA
    J Child Adolesc Psychopharmacol 19:415-22. 2009

Detail Information

Publications24

  1. ncbi request reprint Treatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom setting
    Raul Silva
    New York University Child Study Center, New York, NY, USA
    Psychopharmacol Bull 41:19-33. 2008
    ..No serious adverse events were reported. Treatment with either agent was associated with significant improvements in ADHD symptoms. d-MPH-ER and d,l-MPH-ER can be differentiated on what part of the day each is more effective...
  2. ncbi request reprint Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting
    Raul Silva
    Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA
    J Child Adolesc Psychopharmacol 15:637-54. 2005
    ..The aim of this study was to compare efficacy and safety of two long-acting formulations of methylphenidate (MPH) for attention-deficit/hyperactivity disorder (ADHD) in school-age children...
  3. ncbi request reprint A rating scale for disruptive behavior disorders, based on the DSM-IV item pool
    Raul R Silva
    Division of Child and Adolescent Psychiatry, NYU School of Medicine, New York 10016, USA
    Psychiatr Q 76:327-39. 2005
    ..There was a great deal of comorbidity among diagnostic groups...
  4. ncbi request reprint Administrative issues in child psychiatry
    Raul R Silva
    Department of Child and Adolescent Psychiatry, New York University School of Medicine, 550 First Avenue, New York, NY 10016 9196, USA
    Psychiatr Q 78:199-210. 2007
    ..In order to continue thriving, programs need to be efficient and fiscally viable. Issues such as building the continuum of care and finding the qualified personnel to staff these services are discussed in this article...
  5. ncbi request reprint Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder
    Raul R Silva
    New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Child Adolesc Psychopharmacol 16:239-51. 2006
    ..The aim of this study was to assess changes in symptomatology of attention-deficit/ hyperactivity disorder (ADHD) with extended-release dexmethylphenidate (d-MPHER) versus placebo in a laboratory classroom setting...
  6. ncbi request reprint Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder
    Raul Silva
    New York University School of Medicine, New York, New York 10016, USA
    J Child Adolesc Psychopharmacol 14:555-63. 2004
    ..This pilot study examined the efficacy and duration of the effect of dexmethylphenidate (d-MPH) given once-daily in subjects with attention deficit hyperactivity disorder (ADHD)...
  7. doi request reprint Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder
    Raul R Silva
    New York University Child Study Center, NYU School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Am Acad Child Adolesc Psychiatry 47:199-208. 2008
    ..This study compared once-daily dexmethylphenidate extended release (D-MPH-ER) 20 mg/day and placebo over 12 hours in children ages 6 to 12 with attention-deficit/hyperactivity disorder (ADHD) in a laboratory classroom setting...
  8. ncbi request reprint Early intervention with traumatized children
    Raul R Silva
    Child Study Center, Division of Child and Adolescent Psychiatry, Department of Psychiatry, New York University School of Medicine, New 550 First Avenue NB21S6, New York, NY 10016, USA
    Psychiatr Q 74:333-47. 2003
    ..We will also briefly review the available literature on the psychopharmacologic interventions to help guide the physician when confronted with such treatment decisions...
  9. ncbi request reprint Dexmethylphenidate extended-release capsules for the treatment of attention deficit hyperactivity disorder
    Sharon Kowalik
    New York University School of Medicine, New York, USA
    Expert Opin Pharmacother 7:2547-57. 2006
    ..5 h post-dose. Laboratory classroom studies have demonstrated clinically and statistically meaningful efficacy throughout a 12-h day. Pharmacokinetics, safety and efficacy data are reviewed...
  10. pmc Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review
    Rachel Neuhut
    Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA
    J Child Adolesc Psychopharmacol 19:415-22. 2009
    ..The purpose of this report is to examine the published cases of NMS in children and adolescents receiving atypical antipsychotic medication and review early warning symptoms, risk factors, and treatment in this population...
  11. ncbi request reprint The use of psychostimulants in pervasive developmental disorders
    Patricia Karen Abanilla
    Division of Child and Adolescent Psychiatry, New York University School of Medicine, NY 10016 9196, USA
    Psychiatr Q 76:271-81. 2005
    ..Finally, this review will also attempt to define potential areas of future research to examine the utility of the psychostimulants in children and adolescents with PDD and symptoms of ADHD...
  12. ncbi request reprint Review and comparison of the long acting methylphenidate preparations
    Feng Liu
    The Division of Child and Adolescent Psychiatry, New York University School of Medicine, NY 10016 9196, USA
    Psychiatr Q 76:259-69. 2005
    ..Finally, we will suggest based on a theoretical framework on how to approach selecting an agent based on the results of these trials and the individual needs of the patient...
  13. ncbi request reprint Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children: A viewpoint by Raul R. Silva
    Raul R Silva
    New York University School of Medicine, New York, New York, USA
    Drugs 66:1127-8; discussion 1128. 2006
  14. ncbi request reprint Critical assessment of the methylphenidate transdermal system
    Sharon Kowalik
    Division of Child and Adolescent Psychiatry, New York University School of Medicine, New York, New York 10016, USA
    Drugs Today (Barc) 43:515-27. 2007
    ..Efficacy was demonstrated at all time points measured in ADHD, from 2-12 hours. Most adverse events reported were mild to moderate in severity; the most frequent adverse events reported were disturbances in sleep and appetite...
  15. ncbi request reprint Effectiveness of a children's home and community-based services waiver program
    Ramon Solhkhah
    The Child and Family Institute at St Luke s and Roosevelt Hospitals, 411 West 114th Street, New York, NY 10025, USA
    Psychiatr Q 78:211-8. 2007
    ..Community-based interventions are intended to offer less restrictive and expensive options than traditional treatment. One such program is New York State's Home and Community-Based Services (HCBS) Waiver Program...
  16. ncbi request reprint Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant
    Murray Alpert
    Department of Psychiatry, New York University Medical Center, 550 First Avenue, New York, NY 10016, USA
    J Clin Psychopharmacol 23:309-13. 2003
    ..Further study of FOL interaction with SSRI is warranted. For the group treated with the SSRI, baseline FOL level was a more efficient predictor of improvement, especially for results on a self-rating depression scale (POMS)...
  17. ncbi request reprint Review of benzodiazepine use in children and adolescents
    Malgorzata W Witek
    Division of Child and Adolescent Psychiatry, New York University School of Medicine, NY 10016 9196, USA
    Psychiatr Q 76:283-96. 2005
    ..In this paper we will review the available literature on benzodiazepine use in the child and adolescent population, focusing primarily on psychiatric applications...
  18. ncbi request reprint The effect of atypical antipsychotic agents on prolactin levels in children and adolescents
    Mia Pappagallo
    Department of Psychiatry, Division of Child and Adolescent Psychiatry, New York University School of Medicine, New York, NY 10016, USA
    J Child Adolesc Psychopharmacol 14:359-71. 2004
    ..Discussion of pertinent medical differential and treatment options are also reported...
  19. ncbi request reprint Psychometric properties of Darryl, a cartoon based measure to assess community violence-related PTSD in children
    Pamela A Geller
    Department of Psychology, Drexel University, 245 N 15th St, Mail Stop 515, Philadelphia, PA 19102, USA
    Psychiatr Q 78:157-68. 2007
    ..To examine the reliability and validity of Darryl, a cartoon-based measure of PTSD symptoms and a screening tool for identifying children and adolescents with a PTSD diagnosis...
  20. ncbi request reprint Psychopharmacology news
    Raul R Silva
    J Child Adolesc Psychopharmacol 15:iv. 2005
  21. ncbi request reprint Psychopharmacology news
    Raul R Silva
    J Child Adolesc Psychopharmacol 14:159-60. 2004
  22. ncbi request reprint Psychopharmacology news
    Raul R Silva
    J Child Adolesc Psychopharmacol 13:409-10. 2003
  23. ncbi request reprint Recent pharmacologic updates
    Raul R Silva
    J Child Adolesc Psychopharmacol 15:715-6. 2005